In this study, we evaluate the clinical significance of the PRSS3 and Wiskott–Aldrich syndrome protein family verprolin-homologous protein 1 (WAVE1) in patients with epithelial ovarian cancer (EOC) by immunohistochemistry.
In current study, all adjacent non-cancerous tissues showed absent or low expression of PRSS3. The expression of PRSS3 was significantly increased in the EOCs than adjacent non-cancerous tissues. Moreover, the expression of WAVE1 was significantly observed in all EOC tissues when compared with normal tissues. Furthermore, WAVE1 expression was absent in 35 (89.74 %) adjacent non-cancerous tissues.
Our findings showed that high expression of PRSS3 was markedly linked to FIGO stage (P = 0.02), advanced grade (P = 0.017), and lymph node metastases (P = 0.001), but no relationship was determined with other clinicopathological parameters. Furthermore, high expression of WAVE1 was significantly correlated with FIGO stage (P = 0.001), grade of tumor (P = 0.011), and residual tumor size (P = 0.041), but no significant associations were found between WAVE1 expression and age, lymph node metastasis, and histological subtypes (all P > 0.05). In conclusion, our study showed that increased expression of PRSS3 and WAVE1 may be involved in development of EOC.
Epithelial ovarian cancer PRSS3 WAVE1 Tissues Expression
This is a preview of subscription content, log in to check access.
Paju A, Stenman UH. Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor. Crit Rev Clin Lab Sci. 2006;43:103–42.CrossRefPubMedGoogle Scholar
Ma R, Ye X, Cheng H, Ma Y, Cui H, Chang X. PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer. Gynecol Oncol. 2015;137(3):546–52.CrossRefPubMedGoogle Scholar
Diederichs S, Bulk E, Steffen B, Ji P, Tickenbrock L, Lang K. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res. 2004;64:5564–9.CrossRefPubMedGoogle Scholar
Jiang G, Cao F, Ren G, Gao D, Bhakta V, Zhang Y. PRSS3 promotes tumor growth and metastasis of human pancreatic cancer. Gut. 2010;59:1535–44.CrossRefPubMedGoogle Scholar
Takenawa T, Miki H. WASP and WAVE family proteins: key molecules for rapid rearrangement of cortical actin filaments and cell movement. J Cell Sci. 2001;114(10):1801–9.PubMedGoogle Scholar
Fernando HS, Sanders AJ, Kynaston HG, Jiang WG. WAVE1 is associated with invasiveness and growth of prostate cancer cells. J Urol. 2008;180(4):1515–21.CrossRefPubMedGoogle Scholar
Akeuchi T, Shuman MA, Craik CS. Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci U S A. 1999;96:11054–61.CrossRefGoogle Scholar
Dozmorov MG, Hurst RE, Culkin DJ, Kropp BP, Frank MB, Osban J. Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells. Prostate. 2009;69:1077–90.CrossRefPubMedPubMedCentralGoogle Scholar
Hockla A, Miller E, Salameh MA, Copland JA, Radisky DC, Radisky ES. PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer. Mol Cancer Res. 2012;10(12):1555–66.CrossRefPubMedPubMedCentralGoogle Scholar
Hockla A, Radisky DC, Radisky ES. Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109. Breast Cancer Res Treat. 2010;124:27–38.CrossRefPubMedGoogle Scholar
Yamashita K, Mimori K, Inoue H, Mori M, Sidransky D. A tumor-suppressive role for trypsin in human cancer progression. Cancer Res. 2003;63:6575–8.PubMedGoogle Scholar
Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis. 2006;27:112–6.CrossRefPubMedGoogle Scholar
Fernando HS, Davies SR, Chhabra A, Watkins G, Douglas-Jones A, Kynaston H. Expression of the WASP verprolin-homologues (WAVE members) in human breast cancer. Oncology. 2007;73(5–6):376–83.CrossRefPubMedGoogle Scholar
Cai X, Xiao T, James SY, Da J, Lin D, Liu Y. Metastatic potential of lung squamous cell carcinoma associated with HSPC300 through its interaction with WAVE2. Lung Cancer. 2009;65(3):299–305.CrossRefPubMedGoogle Scholar
Burns S, Cory GO, Vainchenker W, Thrasher AJ. Mechanisms of WASP-mediated haematological and immunological disease. Blood. 2004;104:3454–62.CrossRefPubMedGoogle Scholar
He YL, Cao LZ, Yang MH, Zhao MY, Yu Y, Xu WQ. Role of WAVE1 in K562 leukemia cells invasion and its mechanism. Zhonghua Xue Ye Xue Za Zhi. 2009;30(4):237–41.PubMedGoogle Scholar
Iwaya K, Norio K, Mukai K. Coexpression of Arp2 and WAVE2 predicts poor outcome in invasive breast carcinoma. Mod Pathol. 2007;20(3):339–43.CrossRefPubMedGoogle Scholar
Yang LY, Tao YM, Ou DP, Wang W, Chang ZG, Wu F. Increased expression of Wiskott–Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma. Clin Cancer Res. 2006;12(19):5673–9.CrossRefPubMedGoogle Scholar
Zhang J, Tang L, Shen L, Zhou S, Duan Z, Xiao L, et al. High level of WAVE1 expression is associated with tumor aggressiveness and unfavorable prognosis of epithelial ovarian cancer. Gynecol Oncol. 2012;127(1):223–30.CrossRefPubMedGoogle Scholar